Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
AACE Endocrinology and Diabetes is Scopus-indexed (Q3, CiteScore 2.1), WoS ESCI. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 3050-9157Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 178 / 250 | 29th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2025–present, best quartile Q3, CiteScore 2.1.
AACE Endocrinology and Diabetes is Q3 in Endocrinology, Diabetes and Metabolism (rank 178 of 250), by CiteScore 2025.
AACE Endocrinology and Diabetes is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.1, which places it in quartile Q3 at the 29th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.253, quartile Q4, with an H-index of 17.
AACE Endocrinology and Diabetes is published by Elsevier B.V. Its ISSN is 3050-9157.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
AACE Endocrinology and Diabetes has an h-index of 5 and a 2-year mean of 0.43 citations per paper (OpenAlex). Its Scopus CiteScore is 2.1, quartile Q3. On 2-year citations it ranks #204 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
AACE Endocrinology and Diabetes published 150 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2026), authors are most often from United States (56.5%), India (7.1%) and Bangladesh (4.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.